Transaction #3349 · Form 4 · 0001640334-25-001925
ARTELO BIOSCIENCES, INC. · Conversion · Warrant (right to buy)
ARTELO BIOSCIENCES, INC. · Transacted October 28, 2025 · Filed October 30, 2025
What does this filing report?
An SEC Form 4 filing for ARTELO BIOSCIENCES, INC. records a conversion involving Warrant (right to buy) on October 28, 2025. The reported quantity was 38,346. The filing date is October 30, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- ARTELO BIOSCIENCES, INC.
- Company CIK
- 0001621221
- Security type
- Derivative
- Acquisition type
- Conversion · Code C
- Quantity acquired
- 38,346
- Reported price
- Not reported · See footnotes
- Reference value
- Not reported
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 38,346
- Ownership description
- Not reported
- SEC acceptance time
- Oct 30, 2025, 9:30 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- MATSUI CONNIE ↗
Director
CIK 0001236537
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 38,346
- Conversion / exercise price
- 6.24
- Exercise date
- October 28, 2025
- Expiration date
- October 28, 2030
Filing footnotes & remarks
- F1
- Pursuant to the terms of the convertible note issued to the Reporting Person on May 1, 2025 (the "May Note"), on October 28, 2025, a portion of the May Note was automatically converted into a warrant to purchase shares of the Issuer's common stock ("Common Stock") (the "$6.24 Warrant").
- F2
- On October 28, 2025, the Issuer entered into a Subscription Agreement (the "Subscription Agreement") pursuant to which certain investors, including the Reporting Person, converted and reinvested the portion of the May Note not converted into the $6.24 Warrant into (i) a convertible note (the "October Note"), and (ii) a warrant to purchase shares of the Issuer's Common Stock pursuant to the Subscription Agreement (the "$3.40 Warrant"). At any time prior to payment in full of the principal amount of the October Note, the Reporting Person has the right to convert the principal amount of the October Note, together with the accrued and unpaid interest thereon, into shares of the Issuer's Common Stock.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.